Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00704340 · ClinicalTrials.gov registry record · NA
DuraSeal Sealant Post Market Study
A NA study, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- NA
- Development phase
- 237
- Enrollment target
NCT00704340 is a NA study that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 237 participants.
The verdict
NCT00704340, a NA study, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 237 participants
- Enrollment target
Study Summary
DuraSeal Dural Sealant has been approved as a dural sealant by the FDA for use in cranial and spinal procedures. This study was completed to further evaluate the safety of the DuraSeal Sealant in a post-approval setting as compared to control (defined as methods typically employed by surgeons to seal the dura).
Interventions
- OTHER Standard of Care
- DEVICE DuraSeal Dural Sealant System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00704340
The ClinicalTrials.gov registry entry for NCT00704340 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 237 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT00704340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00704340 about?
NCT00704340 is a clinical study titled "DuraSeal Sealant Post Market Study". DuraSeal Dural Sealant has been approved as a dural sealant by the FDA for use in cranial and spinal procedures. This study was completed to further evaluate the safety of the DuraSeal Sealant in a post-approval setting as compared to control (defined as methods typically employed by surgeons to sea...
What is the current status of trial NCT00704340?
This trial is currently completed. It is a NA study. The enrollment target is 237 participants. The study started on 2005-09. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00704340?
The interventions under investigation include: Standard of Care (OTHER), DuraSeal Dural Sealant System (DEVICE).
Who is sponsoring clinical trial NCT00704340?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.